Table 4 Physician and patient global assessments of overall health status

From: Tiotropium in patients with moderate COPD naive to maintenance therapy: a randomised placebo-controlled trial

 

Tiotropium

Placebo

P value

 

Baseline

Week 24

Baseline

Week 24

 

Physician’s assessment

 Poor/fair

78 (34.4%)

41 (19.0%)

62 (30.0%)

51 (25.4%)

 

 Good

132 (58.1%)

136 (63.0%)

122 (58.9%)

128 (63.7%)

 

 Excellent

17 (7.5%)

39 (18.1%)

23 (11.1%)

22 (10.9%)

0.045

Patient’s self-assessment

 Poor/fair

95 (41.9%)

56 (25.9%)

72 (35.0%)

66 (32.8%)

 

 Good

117 (51.5%)

128 (59.3%)

111 (53.9%)

116 (57.7%)

 

 Excellent

15 (6.6%)

32 (14.8%)

23 (11.2%)

19 (9.5%)

0.086

  1. Patients and physicians could judge the overall health status as poor, fair, good, or excellent. ‘Poor’ and ‘fair’ were pooled. Data are prevalence of the scores with percentages in parentheses.
  2. P values relate to the outcome of the chi-square test.
Back to article page